Cite
HARVARD Citation
Sakai, F. et al. (2021). Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients. Headache. 61 (7), pp. 1092-1101. [Online].